Stay updated on Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Sign up to get notified when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.

Latest updates to the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page
- Check4 days agoChange DetectedNo significant additions or deletions were observed on the page; the study details, eligibility criteria, and trial status appear unchanged.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page now includes an expanded Locations section with participating sites across multiple regions (e.g., Arkansas, California, Bavaria, Rome, Scotland, etc.) and notes Revision: v3.3.3.SummaryDifference2%

- Check18 days agoChange DetectedMinor UI/layout differences observed between screenshots, with no changes to core study data or eligibility criteria; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page footer revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe government funding lapse notice at the top of the page has been removed. This notice previously warned that information may not be up to date and operations could be limited.SummaryDifference0.4%

- Check47 days agoChange DetectedNo significant changes detected; the page content and layout appear identical.SummaryDifference0.1%

Stay in the know with updates to Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.